192 related articles for article (PubMed ID: 15379619)
1. Antiplatelet therapy in peripheral arterial disease.
Aronow WS
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Sep; 4(3):265-7. PubMed ID: 15379619
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
Greenhalgh J; Bagust A; Boland A; Martin Saborido C; Oyee J; Blundell M; Dundar Y; Dickson R; Proudlove C; Fisher M
Health Technol Assess; 2011 Sep; 15(31):1-178. PubMed ID: 21888837
[TBL] [Abstract][Full Text] [Related]
3. Rationale for the use of platelet aggregation inhibitors in PAD patients.
Agnelli G
Vasc Med; 2001; 6(3 Suppl):13-5. PubMed ID: 11789961
[TBL] [Abstract][Full Text] [Related]
4. Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy.
Hiatt WR
J Intern Med; 2002 Mar; 251(3):193-206. PubMed ID: 11886478
[TBL] [Abstract][Full Text] [Related]
5. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Tran H; Anand SS
JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
[TBL] [Abstract][Full Text] [Related]
6. Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events. CAPRA (CAPRIE Actual Practice Rates Analysis) Study Group. Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events.
Caro JJ; Migliaccio-Walle K
Am J Med; 1999 Dec; 107(6):568-72. PubMed ID: 10625025
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
Aronow WS
Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
[TBL] [Abstract][Full Text] [Related]
8. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.
CAPRIE Steering Committee
Lancet; 1996 Nov; 348(9038):1329-39. PubMed ID: 8918275
[TBL] [Abstract][Full Text] [Related]
9. The role of platelets in peripheral arterial disease: therapeutic implications.
Matsagas MI; Geroulakos G; Mikhailidis DP
Ann Vasc Surg; 2002 Mar; 16(2):246-58. PubMed ID: 11972262
[TBL] [Abstract][Full Text] [Related]
10. [Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
Dörffler-Melly J; Schmidli J; Mahler F
Ther Umsch; 2003 Jan; 60(1):36-42. PubMed ID: 12638477
[TBL] [Abstract][Full Text] [Related]
11. Clopidogrel: a review of its use in the prevention of atherothrombosis.
Jarvis B; Simpson K
Drugs; 2000 Aug; 60(2):347-77. PubMed ID: 10983738
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet therapy in the treatment of atherothrombotic disease: considering the evidence.
Aronow WS
Geriatrics; 2007 Apr; 62(4):12-24. PubMed ID: 17408314
[TBL] [Abstract][Full Text] [Related]
14. [Antiplatelet therapy in patients with peripheral arterial disease (PAD)].
Diehm C; Lawall H; Huber R
Med Klin (Munich); 2004 Aug; 99 Suppl 1():14-20. PubMed ID: 15487853
[TBL] [Abstract][Full Text] [Related]
15. Risk reduction with clopidogrel in the management of peripheral arterial disease.
Nayak KR; Cavendish JJ
Vasc Health Risk Manag; 2007; 3(3):289-97. PubMed ID: 17703636
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic therapy in peripheral arterial occlusive disease.
Jackson MR; Clagett GP
Chest; 1998 Nov; 114(5 Suppl):666S-682S. PubMed ID: 9822070
[No Abstract] [Full Text] [Related]
17. Value of antiplatelet therapy in preventing thrombotic events in generalized vascular disease.
Montalescot G
Clin Cardiol; 2000 Nov; 23 Suppl 6(Suppl 6):VI-18-22. PubMed ID: 11129682
[TBL] [Abstract][Full Text] [Related]
18. Emerging drugs in peripheral arterial disease.
Tulsyan N; Ouriel K; Kashyap VS
Expert Opin Emerg Drugs; 2006 Mar; 11(1):75-90. PubMed ID: 16503827
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet agents and randomized trials.
Diener HC
Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
[TBL] [Abstract][Full Text] [Related]
20. Clopidogrel for cerebrovascular prevention.
Paciaroni M; Bogousslavsky J
Cerebrovasc Dis; 1999; 9(5):253-60. PubMed ID: 10473907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
